Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

HIV RT inhibitors available for licensing from NIH

Jan. 15, 1998

Progenics, Roche collaborate on next-generation anti-HIV agents

Jan. 15, 1998

Novartis discloses HIV protease inhibitors with excellent pharmacodynamic profile

Jan. 14, 1998

Novel AIDS therapy shows promise

Jan. 14, 1998

Ribozyme HIV gene therapy demonstrates potential in phase I/II

Jan. 13, 1998

Anti-HIV fusion inhibitor from Trimeris advances to phase II

Jan. 12, 1998

Japanese launch announced for HIV protease inhibitor

Jan. 12, 1998

New antiviral agents emerge from European research collaboration

Jan. 9, 1998

Second-generation CMV retinitis compound enters phase I/II

Jan. 9, 1998

New AIDS treatment candidates disclosed by Vertex

Jan. 8, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...